License Agreements |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||
| License Agreements | |||||||||||||||||||||||||||||||||||||||||||
| License Agreements |
Note 7 – License Agreements
We have entered into license agreements which allow us to develop, manufacture, and/or commercialize the following drug assets: Schedule of License Agreements
For more information, you should refer to the summaries described in the Business section of this Annual Report and the copies of such agreements, which have been filed as exhibits to this Annual Report.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition License Agreement Disclosure [Text Block] No definition available.
|